CoChat

Patient-reported outcomes and their role in the assessment of rheumatoid arthritis

Lubeck, Deborah P. · 2004 · PharmacoEconomics

The DOI matches its Crossref record; 95 of the 97 references it cites were found in a registry or an index.

Abstract

Patients with rheumatoid arthritis (RA) face considerable physical, social and emotional disabilities. In this chronic disease, for which a cure is not yet available, improving patients' health-related quality of life (HRQoL) is of the utmost concern, particularly as the use of long-term and potentially toxic therapy increases. Early HRQoL outcome measures in RA focused on physical functioning, but the social and emotional aspects of the disease are now increasingly important. Thus, several generic and RA-specific HRQoL instruments have been developed, but no one tool covers all areas of HRQoL that affect the patient with RA. For this reason, a combination of generic and disease-specific tools is currently recommended for RA clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.2165/00019053-200422001-00004

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Research works printed but not linked: 8

  1. Singh G, Lingala B, Bennett M, Wanke L, Singh A. Epidemiology of fatigue in rheumatoid arthritis: prevalence and clinical correlates. Presented at EULAR 2003, Lisbon, Portugal
  2. Singh G, Lingala B, Bennett M, Wanke L, Singh A. Fatigue in rheumatoid arthritis: significant correlation with direct medical costs and missed days of work. Presented at EULAR 2003, Lisbon, Portugal
  3. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE, Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000; 43 (7): 1478–87 · DOI · Paper page
  4. Singh A, Wanke LA, Parasuraman TV, Lubeck D. Reliability and validity of SF-36 vitality scale in measuring vitality of methotrexate-naive patients with early, active rheumatoid arthritis. Presented at American College of Rheumatology 2002
  5. Katz PP, Yelin EH, Lubeck DP, Wanke LA, Buatti MC. Satisfaction with function: what type of function do rheumatoid arthritis patients value most? Arthritis Rheum 2001; 44 Suppl. Abstract 793
  6. Singh A, Sato R, Wanke L. How much improvement in functioning is considered important by patients with active refractory rheumatoid arthritis. Ann Rheum Dis 2003; 62 Suppl. 2: 108
  7. Kosinski M, Martin R, Henkenius S, Wanke LA, Buatti M. Determining clinically meaningful improvement in SF-36 scale scores for treatment studies in rheumatoid arthritis. Arthritis Rheum 2000; 43 Suppl.: 140
  8. Singh G, Sato R, Parasuraman TV, Wanke L, Wyeth Research, Amgen. How much improvement in functional status is considered important by patients with MTX-naïve early rheumatoid arthritis: a comparison with DMARD-refractory patients. Presented at the ACR/ARHP Annual Scientific Meeting 2003, October 24–28, 2003; Florida.

Cited by

See all 124

Metadata

Authors
Lubeck, D. P.
Affiliations
Stanford University (US)
Corresponding author
Lubeck, Deborah P.
Venue
PharmacoEconomics
Published
2004-09
Volume
22
Issue
S1
Pages
27-38
ISSN
  • 1170-7690 (ISSN-L)
  • 1179-2027
OpenAlex
W2123408911
Cited by
123
References
97
Citations by year
2026: 3 · 2025: 4 · 2024: 8 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 13 · 2014: 6 · 2013: 5 · 2012: 4
FWCI
0.71
Type
journal article
Language
en
Open access
closed
Locations
  • PharmacoEconomics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
rheumatoid arthritis, patient-reported outcomes, health-related quality of life, disease-specific outcome measures, generic outcome measures, physical function, clinical trial outcome assessment
MeSH terms
Arthritis, Rheumatoid, Humans, Quality of Life, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient-reported outcomes and their role in the assessment of rheumatoid arthritis. https://app.cochat.ai/papers/10.2165/00019053-200422001-00004
The paper
Lubeck, D. P. (2004). Patient-reported outcomes and their role in the assessment of rheumatoid arthritis. PharmacoEconomics. https://doi.org/10.2165/00019053-200422001-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.